Journey Medical Corp (DERM)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Journey Medical Corp reported revenue of $61.24M, up 11.1% from the prior year. The company ran a net loss, with a net margin of -18.7%. It held $94.59M in total assets against $62.74M in total liabilities.
Key ratios (FY2025)
-13.3%
Operating margin
-18.7%
Net margin
-35.9%
Return on equity
+11.1%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $61.24M | $55.13M | $59.66M | $71.00M | $63.13M | $44.53M | — |
| Cost of Revenue | $20.92M | $20.88M | $22.89M | $30.77M | $32.08M | $14.59M | — |
| Operating Income | -$8.17M | -$13.68M | -$2.07M | -$27.52M | -$34.88M | $7.85M | — |
| Net Income | -$11.43M | -$14.67M | -$3.85M | -$29.63M | -$43.99M | $5.28M | — |
| EPS (Diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 | — |
| Total Assets | $94.59M | $80.24M | $76.85M | $105.16M | $97.28M | $51.91M | — |
| Total Liabilities | $62.74M | $60.17M | $56.50M | $88.18M | $55.24M | $41.61M | — |
| Shareholders' Equity | $31.85M | $20.07M | $20.35M | $16.98M | $42.04M | $10.29M | $2.75M |
| Cash & Equivalents | $24.09M | $20.30M | $27.44M | $32.00M | $49.08M | $8.25M | — |
| Operating Cash Flow | -$12.44M | -$9.13M | $5.24M | -$13.53M | -$2.18M | $5.13M | — |
| Capital Expenditures | — | $15.00M | $5.00M | $20.00M | — | — | — |
| Shares Outstanding | 24.50M | 20.43M | 18.23M | 17.53M | 10.19M | 10.84M | — |